Maryl R. Johnson

23.4k total citations · 1 hit paper
56 papers, 2.4k citations indexed

About

Maryl R. Johnson is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Maryl R. Johnson has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 26 papers in Cardiology and Cardiovascular Medicine and 13 papers in Biomedical Engineering. Recurrent topics in Maryl R. Johnson's work include Transplantation: Methods and Outcomes (21 papers), Mechanical Circulatory Support Devices (13 papers) and Cardiac Structural Anomalies and Repair (12 papers). Maryl R. Johnson is often cited by papers focused on Transplantation: Methods and Outcomes (21 papers), Mechanical Circulatory Support Devices (13 papers) and Cardiac Structural Anomalies and Repair (12 papers). Maryl R. Johnson collaborates with scholars based in United States, Australia and Denmark. Maryl R. Johnson's co-authors include Alain Heroux, Maria Rosa Costanzo‐Nordin, E. Jeanne O'Sullivan, Susan G. Fisher, R Pifarré, Richard I. Fisher, Lode J. Swinnen, George J. Dizikes, Melvin L. Marcus and Richard E. Kerber and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Maryl R. Johnson

54 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients

1990 724 citations Maria Rosa Costanzo‐Nordin, E. Jeanne O'Sullivan et al. profile →

Peers

Countries citing papers authored by Maryl R. Johnson

Since Specialization

Citations

This map shows the geographic impact of Maryl R. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryl R. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryl R. Johnson more than expected).

Fields of papers citing papers by Maryl R. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryl R. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryl R. Johnson. The network helps show where Maryl R. Johnson may publish in the future.

Co-authorship network of co-authors of Maryl R. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Maryl R. Johnson. A scholar is included among the top collaborators of Maryl R. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryl R. Johnson. Maryl R. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Post-Transplant Stroke in Patients Bridged to Transplantation With Impella 5.5 in the Era of Prolonged Duration of Support 2025 ·ASAIO Journal ·(unknown), (unknown), Joshua L. Hermsen, Maryl R. Johnson, Veli K. Topkara	0
2	Heart Transplantation—Postoperative Considerations 2023 ·Critical Care Clinics ·(unknown), Robert T. Arrigo, (unknown), Maryl R. Johnson	3
3	Proceedings from the metrics forum in heart transplantation for performance monitoring 2021 ·American Journal of Transplantation ·Jon Kobashigawa, Shelley Hall, Maryjane Farr, Emily A. Blumberg, A. Michael Borkon, Monica Colvin, Hannah Copeland, Howard J. Eisen, Maryl R. Johnson, Ulrich P. Jorde, Kiran K. Khush, James K. Kirklin, J. Patel, Sean Pinney, (unknown), Jesse D. Schold, Josef Stehlik	3
4	Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative 2020 ·The Journal of Heart and Lung Transplantation ·(unknown), Mandeep R. Mehra, (unknown), Maryl R. Johnson, Michael Perch, Marie Budev, Yousef Zakharia, Richard K. Cheng, José Nativi-Nicolau, Josef Stehlik	14
5	Evaluation for Heart Transplantation and LVAD Implantation 2020 ·Journal of the American College of Cardiology ·Maya Guglin, Mark Zucker, Barry A. Borlaug, (unknown), Joseph C. Cleveland, Maryl R. Johnson, Gurusher Panjrath, J. Patel, Randall C. Starling, Biykem Bozkurt	82
6	Amiodarone Use Prior to Cardiac Transplant Impacts Early Post-Transplant Survival 2020 ·Cardiovascular Drugs and Therapy ·Salman Allana, (unknown), Jason W. Smith, Lucian Lozonschi, Jinn‐Ing Liou, Maryl R. Johnson, Takushi Kohmoto, Ravi Dhingra	1
7	A novel approach to prevent post-operative ileus after continuous-flow left ventricular assist device implantation: A retrospective cohort study 2015 ·International Journal of Surgery ·Abbasali Badami, (unknown), Margaret Murray, Maryl R. Johnson, Shahab A. Akhter, Lucian Lozonschi, Satoru Osaki, Entela B. Lushaj, Takushi Kohmoto	3
8	Double Dose vs. Standard Dose Influenza Vaccination in Patients with Heart Failure: A Pilot Study 2013 ·European Journal of Heart Failure ·(unknown), (unknown), John M. Moran, Nancy K. Sweitzer, Maryl R. Johnson, Orly Vardeny	23
9	Management of allosensitized cardiac transplant candidates 2009 ·Transplantation Reviews ·Mauricio Velez, Maryl R. Johnson	44
10	The potential of cardiac allografts from donors after cardiac death at the University of Wisconsin Organ Procurement Organization☆ 2009 ·European Journal of Cardio-Thoracic Surgery ·Satoru Osaki, James E. Anderson, Maryl R. Johnson, Niloo M. Edwards, Takushi Kohmoto	28
11	The β2 Adrenergic Receptor Gln27Glu Polymorphism Affects Insulin Resistance in Patients With Heart Failure: Possible Modulation by Choice of Beta Blocker 2008 ·Journal of Cardiovascular Pharmacology ·Orly Vardeny, Michelle A. Detry, John J. Moran, Maryl R. Johnson, Nancy K. Sweitzer	10
12	The Challenge of Rejection and Cardiac Allograft Vasculopathy 2001 ·Heart Failure Reviews ·William Cotts, Maryl R. Johnson	20
13	Echocardiography for Hemodynamic Assessment of Patients With Advanced Heart Failure and Potential Heart Transplant Recipients 11To discuss this article on line, visit the ACC Home Page at www.acc.org/membersand click on the JACC Forum 1997 ·Journal of the American College of Cardiology ·James H. Stein, Alex Neumann, (unknown), Maria Rosa Costanzo, (unknown), Maryl R. Johnson, (unknown)	70
14	Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation Results of a prospective, randomized multicenter trial 1996 ·Journal of the American College of Cardiology ·Susan C. Brozena, Maryl R. Johnson, Héctor O. Ventura, Robert E. Hobbs, Leslie W. Miller, Maria Teresa Olivari, Barry S. Clemson, Robert C. Bourge, Rebecca Quigg, Roger M. Mills, David C. Naftel	50
15	Clinical follow-up of the heart transplant recipient 1995 ·Current Opinion in Cardiology ·Maryl R. Johnson	4
16	Does heart transplantation confer additional benefit over medical therapy to patients who have waited >6 months for heart transplantation? 1994 ·Journal of the American College of Cardiology ·Walter Kao, Dan McGee, Youlian Liao, Alain Heroux, G. M. Mullen, Maryl R. Johnson, Maria Rosa Costanzo	14
17	Validation by high-frequency epicardial echocardiography of a new method of analyzing coronary angiography quantitatively in coronary artery disease 1993 ·The American Journal of Cardiology ·David D. McPherson, Maryl R. Johnson, Stephen M. Collins, Robert A. Kieso, Melvin L. Marcus, Richard E. Kerber	12
18	Variable morphology of coronary atherosclerosis: Characterization of atherosclerotic plaque and residual arterial lumen size and shape by epicardial echocardiography 1992 ·Journal of the American College of Cardiology ·David D. McPherson, Maryl R. Johnson, (unknown), (unknown), Steve M. Collins, Mark L. Armstrong, Robert A. Kieso, (unknown), Melvin L. Marcus, Richard E. Kerber	25
19	Importance of the timing of cyclosporine initiation in OKT3 treated cardiac transplant patients 1990 ·Journal of the American College of Cardiology ·Maria Rosa Costanzo‐Nordin, Maryl R. Johnson, E. Jeanne O'Sullivan, G. M. Mullen, Diane E. Wallis, Roque Pifarré, Patrick J. Scanlon, John A. Robinson	1
20	Visual estimates of percent diameter coronary stenosis: “A battered gold standard” 1988 ·Journal of the American College of Cardiology ·Melvin L. Marcus, David J. Skorton, Maryl R. Johnson, Steve M. Collins, David G. Harrison, Richard E. Kerber	190

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact